Biomarkers In Cardiovascular Disease (biomarkers In Disease: Methods, Discoveries And Applications)
by Victor R. Preedy /
2016 / English / PDF
22.7 MB Download
On an annual basis, over 17 million people die due to
cardiovascular disease. This represents a third of all global
deaths. The World Health Organisation have identified
cardiovascular disease as the leading cause of death
worldwide. Although many cardiovascular conditions are
preventable, there is a need for accurate characterisation and
diagnosis of cardiovascular conditions before, during and after
treatments. Much of this characterisation entails the use of
biological indicators, i.e biomarkers.
On an annual basis, over 17 million people die due to
cardiovascular disease. This represents a third of all global
deaths. The World Health Organisation have identified
cardiovascular disease as the leading cause of death
worldwide. Although many cardiovascular conditions are
preventable, there is a need for accurate characterisation and
diagnosis of cardiovascular conditions before, during and after
treatments. Much of this characterisation entails the use of
biological indicators, i.e biomarkers.Biomarkers in
Cardiovascular Disease
Biomarkers in
Cardiovascular Disease combines detailed information on
different cardiovascular conditions and the concomitant application
of conventional, new and emerging biomarkers. It covers the latest
knowledge, trends and applications. New platforms are described
which combine advances in biomedical sciences, physics, computing
and chemistry.
combines detailed information on
different cardiovascular conditions and the concomitant application
of conventional, new and emerging biomarkers. It covers the latest
knowledge, trends and applications. New platforms are described
which combine advances in biomedical sciences, physics, computing
and chemistry.
